News Release Archive

Tri-Media is pleased to announce the launch of a new pharmaceutical Web site for licensed-agency Diccicco Battista.

Diccicco Battista designed a Web-site for the new FDA-approved medication Xenazine, which is indicated for the treatment of chorea associated with Huntington's disease.  Sites for such pharmaceuticals are heavily regulated and so tmLiveContent™ site management tool was the perfect engine to power this site. It provides for real-time management of all content, images, forms, password-protected user management and FDA-required ‘blackbox’ statements.

The site was designed to provide information to the various audiences for this ground-breaking drug: patients, caregivers, doctors and pharmacists.

Visit the site: www.xenazineusa.com

About Tri-Media

Now in its 20th year Tri-Media is an award-winning Integrated Marketing Technologies firm serving a global clientele. Since 1986 Tri-Media has delivered proven results through its complete range of digital and traditional marketing solutions including content management systems, digital marketing Application, e-commerce and online reservation tools, crisis communication software and business intelligence tools.

Tri-Media Integrated Marketing Technologies.

Online. Offline. Bottom Line.™

-30-

For further information or to coordinate an interview, contact:
Albert Iannantuono
President, CEO & Founder
Tri-Media Integrated Marketing Technologies Inc.
517 Niagara Street, Welland, Ontario, L3C 1L7
Tel: (905) 732-6431 ext 223
Fax: (905) 732-3028
E-mail: alberti@tri-media.com
Web site: www.tri-media.com